Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Change in Intangibles (2010 - 2015)

Xtant Medical Holdings (XTNT) reported Change in Intangibles of -$57849.0 for Q4 2015, down 196.24% on a QoQ basis from $60106.0 in Q4 2013.

Xtant Medical Holdings (XTNT) has 5 years of Change in Intangibles data on file, last reported at -$57849.0 in Q4 2015.

  • Quarterly Change in Intangibles changed N/A year-over-year to -$57849.0 in Q4 2015, while the trailing twelve-month figure through Dec 2016 was $2257.0 (changed 0.0% YoY) and the FY2015 annual result came in at $73.0 million, changed N/A from the prior year.
  • Change in Intangibles declined to -$57849.0 in Q4 2015 per XTNT's latest filing, from $60106.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $69103.0 in Q1 2011 and bottomed at -$57849.0 in Q4 2015.
  • The 4-year median for Change in Intangibles is $23845.0 (2011), against an average of $21547.3.
  • Peak annual rise in Change in Intangibles reached 2475.05% in 2011, while the deepest fall reached 43.99% in 2011.
  • Tracing XTNT's Change in Intangibles over 4 years: stood at $5444.0 in 2011, then jumped by 105.05% to $11163.0 in 2012, then soared by 438.44% to $60106.0 in 2013, then sank by 196.24% to -$57849.0 in 2015.
  • Per Business Quant, the three latest XTNT Change in Intangibles figures stand at -$57849.0 (Q4 2015), $60106.0 (Q4 2013), and $11163.0 (Q4 2012).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -31.61 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2015 -57,849.00
Dec 31, 2015 -57,849.00
Dec 31, 2013 60,106.00
Dec 31, 2013 60,106.00
Dec 31, 2012 11,163.00
Dec 31, 2012 11,163.00
Dec 31, 2011 5,444.00
Dec 31, 2011 5,444.00
Sep 30, 2011 23,845.00
Sep 30, 2011 23,845.00
Jun 30, 2011 39,019.00
Jun 30, 2011 39,019.00
Mar 31, 2011 69,103.00
Mar 31, 2011 69,103.00
Dec 31, 2010 9,720.00
Dec 31, 2010 9,720.00
Sep 30, 2010 926.00
Sep 30, 2010 926.00